Phosphoglycan Messengers and Their Medical Uses (SLE)

Authors

Khalid M. Elased, Wright State University - Main CampusFollow
Khalid A. Gumaa
Hassan Rahmoune
Thomas Rademacher
J. B. De Souza

Document Type

Patent

Publication Date

1-3-2002

Abstract

PPhosphoglycan messengers (PGMs) which are carbohydrate derivatised phosphatidyl cyclitols are disclosed, together with the finding that these substances are biologically active, especially in modulating plasma cholesterol, plasma triglycerides and/or high density lipoprotein levels and/or modulating the LDL:HDL ratio, and for the treatment of lipodystrophy or dyslipidemia. These compounds are distinct from GPI-anchors disclosed in the prior art as these GPI-anchors are protein linked and are not biologically active.

Comments

WIPO Patent Application WO/2002/000674

Repository Citation

Elased, K. M., Gumaa, K. A., Rahmoune, H., Rademacher, T., & De Souza, J. B. (2002). Phosphoglycan Messengers and Their Medical Uses (SLE). .
https://corescholar.libraries.wright.edu/ptox/146